Skip to main content
SpringerLink
Log in
Book cover

Thyroid Cancer pp 201–210Cite as

The Thyroid Nodule

Evaluation, Risk of Malignancy, and Management

  • Chapter

  • 1539 Accesses

Abstract

Palpable nodules of the thyroid are frequently encountered in clinical practice, and their evaluation requires the physician to be familiar with a growing number of diagnostic tools to identify those nodules representing cases of carcinoma that require surgical intervention. Under most circumstances, what constitutes optimal clinical management of nodular thyroid disease is somewhat controversial (1–6a). However, major professional organizations and the authoritative National Comprehensive Cancer Network have published consensus guidelines for the diagnosis and management of thyroid nodules (7–9).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   269.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   339.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328:553–559.

    Article  PubMed  CAS  Google Scholar 

  2. Burch HB. Evaluation and management of the solid thyroid nodule. Endocrin Metab Clin North Am 1995; 24:663–710.

    CAS  Google Scholar 

  3. Daniels GH. Thyroid nodules and nodular thyroids: A clinical overview. Comp Ther 1996; 22:239–250.

    CAS  Google Scholar 

  4. Ridgway EC. Clinical evaluation of solitary thyroid nodules. In Braverman LE, Utiger RD, editors. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text, 9th ed. Philadelphia: Lippincott, Williams & Wilkins, 2004.

    Google Scholar 

  5. Sheppard MC, Franklyn JA. Management of the single thyroid nodule. Clin Endocrinol 1992; 37:398–401.

    CAS  Google Scholar 

  6. Ridgway EC. Clinical review 30: clinician’s evaluation of a solitary thyroid nodule. J Clin Endocrinol Metab 1992; 74:231–235.

    Article  PubMed  CAS  Google Scholar 

  7. Castro MR, Gharib H. Continuing controversies in the management of thyroid nodules. Ann Intern Med 2005; 142:926–931.

    PubMed  Google Scholar 

  8. Feld S. AACE clinical practice guidelines for the management of thyroid nodules. Endocrine Pract 1996; 2:78–84.

    Google Scholar 

  9. Singer PA, Cooper DA, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well differentiated thyroid cancer. Arch Int Med 1996; 156:2165–2172.

    Article  CAS  Google Scholar 

  10. National Comprehensive Cancer Network (NCCN) Thyroid Carcinoma: Clinical Practice Guidelines 2005, J Natl Comprehensive Cancer Network 2005; 3:404–457.

    Google Scholar 

  11. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Wichham survey. Clin Endocrinol 1977; 7:481–493.

    CAS  Google Scholar 

  12. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules: final report of a 15-year study on the incidence of thyroid malignancy. Ann Intern Med 1968; 69:537–540.

    PubMed  CAS  Google Scholar 

  13. Hopkins CR, Reading CC. Thyroid and parathyroid imaging. Semin Ultrasound CT MR. 1995; 16:279–295.

    Article  PubMed  CAS  Google Scholar 

  14. Horlocker TT, Hay JE, James EM. Prevalence of incidental nodular thyroid disease detected during high resolution parathyroid ultrasonography. In Medeiros-Neto G, Gaitan E, editors. Frontiers in Thyroidology, vol. 1. New York: Plenum Press. 1986; 1309–1312.

    Google Scholar 

  15. Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: ultrasound screening in a random adult population. Radiology 1991; 181:683–687.

    PubMed  CAS  Google Scholar 

  16. Burrow GN. The thyroid: nodules and neoplasia. In Felig P, Baxter JD, Broadus AE, Frohman LA, editors. Endocrinology and Metabolism. New York: McGraw-Hill. 1987; 473–507.

    Google Scholar 

  17. Richter B, Neises G, Clar C. Pharmacotherapy for thyroid nodules: A systematic review and meta-analysis. Endocrinol Metab Clin North Am 2002; 31:699–722.

    Article  PubMed  Google Scholar 

  18. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: Current status and future perspectives. Endocr Rev 2003; 24:102–132.

    Article  PubMed  Google Scholar 

  19. Mazzaferri EL, Young RL, Oertel JE, et al. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine 1977; 56:171–196.

    Article  PubMed  CAS  Google Scholar 

  20. Sarne D, Schneider AB. External radiation and thyroid neoplasia. Endocrin Metab Clin North Am 1996; 25:181–196.

    Article  CAS  Google Scholar 

  21. Ron E, Kleinerman RE, Boice JD Jr, et al. A population-based casecontrol study of thyroid cancer, J Natl Cancer Inst 1987; 79:1–12.

    PubMed  CAS  Google Scholar 

  22. Favus MJ, Schneider AB, Stachura ME, et al. Thyroid cancer occurring as a late consequence of head-and-neck irradiation. N Engl J Med 1976; 294:1019–1025.

    Article  PubMed  CAS  Google Scholar 

  23. DeGroot LJ, Reilly M, Pinnameneni K, Refetoff S. Retrospective and prospective study of radiation-induced thyroid disease. Am J Med 1983; 74:852–862.

    Article  PubMed  CAS  Google Scholar 

  24. Cardis R, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131-I in childhood. J Natl Cancer Institute 2005; 97:724–732.

    Google Scholar 

  25. Boice JD. Radiation-induced thyroid cancer—What’s new? J Natl Cancer Institute 2005; 97:703–705.

    Article  Google Scholar 

  26. Hamburger JI. The autonomously functioning thyroid nodule: Goetsch’s Disease. Endocr Rev 1987; 8:439–447.

    Article  PubMed  CAS  Google Scholar 

  27. Jemal A, Murray T, Ward E, et al., Cancer statistics 2005. Ca: a Cancer Journal for Clinicians 2005; 55:10–30

    Google Scholar 

  28. Sampson RJ, Woolner LB, Bahn RC. Occult thyroid carcinoma in Olmsted County, Minnesota. Prevalence at autopsy compared with that in Hiroshima and Nagasaki. Cancer 1974; 34:2070–2076.

    Article  Google Scholar 

  29. Sampson RJ. Prevalence and significance of occult thyroid cancer. In DeGroot LJ, Frohman LA, Kaplan EL, Refetoff S, editors. Radiation-Associated Thyroid Carcinoma. New York: Grune & Stratton. 1977; 137–143.

    Google Scholar 

  30. McCall A, Jarosz H, Lawrence AM. The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery 1986; 100:1128–1131.

    PubMed  CAS  Google Scholar 

  31. Spencer CA, Wang C-C. Thyroglobulin measurement: Techniques, clinical benefits, and pitfalls. Endocrin Metab Clin North Am 1995; 24:841–864.

    CAS  Google Scholar 

  32. Whitley RJ, Ain KB. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. Clin Lab Med 2004; 24:29–47.

    Article  PubMed  Google Scholar 

  33. Spencer CA, LoPresti JS, Fatemi S, Nicoloff JT. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid 1999; 9:435–441.

    PubMed  CAS  Google Scholar 

  34. Spencer CA, Takeuchi M, Kazaroxyan M, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83:1121–1127.

    Article  PubMed  CAS  Google Scholar 

  35. Marsh DJ, Learoyd DL, Robinson BG. Medullary thyroid carcinoma: recent advances and management update. Thyroid 1995; 5:407–424.

    PubMed  CAS  Google Scholar 

  36. Pacini F, Fontanelli M, Fugazzola L, et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 1994; 78:826–829.

    Article  PubMed  CAS  Google Scholar 

  37. Vitale G, Caraglia M, Ciccarelli A, et al. Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer 2001; 91:1797–1808.

    Article  PubMed  CAS  Google Scholar 

  38. Wells SA Jr, Dilley WG, Farndon JA, et al. Early diagnosis and treatment of medullary thyroid carcinoma. Arch Intern Med 1985; 145:1248–1252.

    Article  PubMed  Google Scholar 

  39. Hanna FWF, Ardill JES, Johnston CF, et al. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid. J Endocrinol 1997; 152:275–281.

    Article  PubMed  CAS  Google Scholar 

  40. Franke WG, Pinkert J, Runge R, et al. Chromogranin A: An additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas? Anticancer Res 2000; 20:5257–5260.

    PubMed  CAS  Google Scholar 

  41. Redding AH, Levine SN, Fowler MR. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid 2000; 10:919–922.

    PubMed  CAS  Google Scholar 

  42. Bockhorn M, Frilling A, Rewerk S, et al. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid 2004; 6:468–470.

    Article  Google Scholar 

  43. Hodak SP, Burman KD. Editorial: The calcitonin conundrum—Is it time for routine measurement of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab 2004; 89:511–514.

    Article  PubMed  CAS  Google Scholar 

  44. Vierhapper H, Raber W, Bieglmayer C, et al. Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 1997; 82:1589–1593.

    Article  PubMed  CAS  Google Scholar 

  45. Hahm JR, Lee MS, Min YK, et al. Routine measuement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 2001; 11:73–80.

    Article  PubMed  CAS  Google Scholar 

  46. Elisei R, Bottici V, Luchetti F, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: Experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004; 89:163–168.

    Article  PubMed  CAS  Google Scholar 

  47. Karanikas G, Moameni A, Poetzi C, et al. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 2004; 89:515–519.

    Article  PubMed  CAS  Google Scholar 

  48. Tommasi M, Brocchi A, Cappellini A, et al. False high serum calcitonin levels using a non-competitive two-site IRMA. J Endocrinol Invest 2001; 24:356–360.

    PubMed  CAS  Google Scholar 

  49. Kotzmann H, Schmidt A, Scheuba C, et al. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma. Thyroid 1999; 9:943–947.

    PubMed  CAS  Google Scholar 

  50. Erdogan MF, Gullu S, Baskal N, et al. Omeprazole: calcitonin stimulation test for the diagnosis, follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab 1997; 82:897–899.

    Article  PubMed  CAS  Google Scholar 

  51. Vlaeminck-Guillem V, D’Herbomez M, Pigny P, et al. Pseudohypoparathyroidism Ia and hypercalcitoninemia. J Clin Endocrinol Metab 2001; 86:3091–3096.

    Article  PubMed  CAS  Google Scholar 

  52. Machens A, Schneyer U, Holzhausen H-J, Dralle H. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 2005; 90:2029–2034.

    Article  PubMed  CAS  Google Scholar 

  53. Oertel YC. Fine needle aspiration and the diagnosis of thyroid cancer. Endocrin Metab Clin North Am 1996; 25:69–92.

    Article  CAS  Google Scholar 

  54. Ravetto C, Colombo L, Dottorini ME. Usefulness of fine needle aspiration in the diagnosis of thyroid carcinoma: a restrospetive study in 37,895 patients. Cancer 2000; 90:357–363.

    Article  PubMed  CAS  Google Scholar 

  55. Gharib H, Goellner JR. Fine needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993; 118:282–289.

    PubMed  CAS  Google Scholar 

  56. Ko HM, Jhu IK, Yang SH, et al. Clinicopathologic analysis of fine needle aspiration cytology of the thyroid. A review of 1613 cases and correlation with histopathologic diagnoses. Acta Cytol 2003; 47:727–732.

    PubMed  Google Scholar 

  57. Harvey JN, Parker D, De P, Shrimali RK, Otter M. Sonographically guided core biopsy in the assessment of thyroid nodules. J Clin Ultrasound 2005; 33:57–62.

    Article  PubMed  Google Scholar 

  58. Danese D, Sciacchitano S, Farsetti A, et al. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid 1998; 8:15–21.

    PubMed  CAS  Google Scholar 

  59. Hatada T, Okada K, Ishii H, et al. Evaluation of ultrasound-guided fineneedle aspiration biopsy for thyroid nodules. Am J Surg 1998; 175:133–136.

    Article  PubMed  CAS  Google Scholar 

  60. Singer PA. Evaluation and management of the thyroid nodule, Otolaryngol. Clin North Am 1996; 29:577–592.

    CAS  Google Scholar 

  61. Backdahl M, Wallin G, Lowhagen T, et al. Fine-needle biopsy cytology and DNA analysis: their place in the evaluation and treatment of patients with thyroid neoplasms Surg Clin North Am 1987; 67:197–211.

    PubMed  CAS  Google Scholar 

  62. Finley DJ, Arora N, Zhu B, et al. Molecular profiling distinguish papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab 2004; 89:3214–3223.

    Article  PubMed  CAS  Google Scholar 

  63. Finley DJ, Lubitz CC, Wei C, Zhu B, Fahey TJ III. Advancing the molecular diagnosis of thyroid nodules: Defining benign lesions by molecular profiling. Thyroid 2005; 15:562–568.

    Article  PubMed  CAS  Google Scholar 

  64. Weber F, Shen L, Aldred MA, et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 2005; 90:2512–2521.

    Article  PubMed  CAS  Google Scholar 

  65. Karwlowski JK, Nowels KW, McDougall IR, Weigel RJ. Needle track seeding of papillary thyroid carcinoma from fine needle aspiration biopsy. A case report. Acta Cytol 2002; 46:591–595.

    Google Scholar 

  66. Baskin HJ. Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes. Thyroid 2004; 14:959–963.

    Article  PubMed  Google Scholar 

  67. Wagner K, Arciaga R, Siperstein A, et al. Thyrotropin receptor/ thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer. J Clin Endocrinol Metab 2005; 90:1921–1924.

    Article  PubMed  CAS  Google Scholar 

  68. Kumar H, Daykin J, Holder R, et al. Gender, clinical findings, and serum thyrotropin measuements in the prediction of thyroid neo-plasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology. Thyroid 1999; 9:1105–1109.

    PubMed  CAS  Google Scholar 

  69. Tollin SR, Mery GM, Jelveh N, et al. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid 2000; 10:235–241.

    PubMed  CAS  Google Scholar 

  70. Marqusee E, Benson CB, Frates MC, et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 2000; 133:696–700.

    PubMed  CAS  Google Scholar 

  71. Shattuck TM, Westra WH, Ladenson PW, Arnold A. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med 2005; 352:2406–2412.

    Article  PubMed  CAS  Google Scholar 

  72. Utiger RD. The multiplicity of thyroid nodules and carcinomas. N Engl J Med 2005; 352:2376–2378.

    Article  PubMed  CAS  Google Scholar 

  73. Bennedbaek FN, Hegedus L. Treatment of rrecurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 2003; 88:5773–5777.

    Article  PubMed  CAS  Google Scholar 

  74. Guglielmi R, Pacella CM, Bianchini A, et al. Percutaneous ethanol injection treatment in benign thyroid lesions: Role and efficacy. Thyroid 2004; 14:125–131.

    Article  PubMed  CAS  Google Scholar 

  75. Mauz PS, Stiegler M, Holderried M, Brosch S. Complications of ultrasound guided percutaneous ethanol injection therapy of the thyroid and parathyroid glands. Ultraschall in der Medizin 2005; 26:111142–5.

    Article  Google Scholar 

  76. Mauz PS, Maassen MM, Braun B, Brosch S. How safe is percutaneous ethanol injection for treatment of thyroid nodules? Report of a case of severe toxic necrosis of the larynx and adjacent skin. Acta Oto-Laryngol 2004; 124:1226–1230.

    Article  CAS  Google Scholar 

  77. Dossing H, Bennedbaek FN, Hegedus L. Ultrasound-guided interstitial laser photocoagulation of an autonomous thyroid nodule: the introduction of a novel alternative. Thyroid 2003; 13:885–888.

    Article  PubMed  Google Scholar 

  78. Corvilain B. The natural history of thyroid autonomy and hot nodules. Ann Endocrinol 2003; 64:17–22.

    CAS  Google Scholar 

  79. Boi F, Lai ML, Deias C, et al. The usefulness of 99mTC-SestaMIBI in the diagnostic evaluation of thyroid nodules with oncocytic cytology. Eur J Endocrinol 2003; 149:493–498.

    Article  PubMed  CAS  Google Scholar 

  80. Maki K, Okumura Y, Sato S, et al. Quantitative evaluation by TI-201 scintigraphy in the diagnosis of thyroid follicular nodules. Ann Nucl Med 17:91–98.

    Google Scholar 

  81. Chang CT, Liu FY, Tsai JJ, et al. The clinical usefulness of dual phase 201Tl thyroid scan for false-negative fine-needle aspiration cytological diagnoses in non-functioning cold thyroid nodules. Anticancer Res 2003; 23:2965–2967.

    PubMed  Google Scholar 

  82. Tamizu A, Okumura Y, Sato S, et al. The usefulness of serum thyroglobulin levels and Tl-201 scintigraphy in differentiating between benign and malignant thyroid follicular lesions. Ann Nucl Med 2002; 16:95–101.

    PubMed  Google Scholar 

  83. Sinha PS, Beeby DI, Ryan P. An evaluation of thallium imaging for detection of carcinoma in clinically palpable solitary, nonfunctioning thyroid nodules. Thyroid 2001; 11:85–89.

    Article  PubMed  CAS  Google Scholar 

  84. Cases JA, Surks MI. The changing role of scintigraphy in the evaluation of thyroid nodules. Semin Nucl Med 2000; 30:81–87.

    Article  PubMed  CAS  Google Scholar 

  85. Meller J, Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med Mol Imaging 2002; 29(Suppl 2):S425–S438.

    Article  PubMed  Google Scholar 

  86. Asari AN, Siegel ME, DeQuattro V. Imaging of medullary thyroid carcinoma and hyperfunctioning adrenal medulla using iodine-131 metaiodobenzylguanidine. J Nucl Med 1986; 27:1858–1860.

    Google Scholar 

  87. Kresnik E, Gallowitsch HH, Mikosch P, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 2003; 133:294–299.

    Article  PubMed  Google Scholar 

  88. Hegedus L. Thyroid ultrasound. Endocrinol Metab Clin North Am 2001; 30:339–360.

    Article  PubMed  CAS  Google Scholar 

  89. Koike E, Noguchi S, Yamashita H, et al. Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg 2001; 136:334–337.

    Article  PubMed  CAS  Google Scholar 

  90. Kakkos SKl Skopa CD, Chalmoukis AK, et al. Relative risk of cancer in sonographically detected thyroid nodules with calcifications. J Clin Ultrasound 2000; 28:347–352.

    Article  PubMed  CAS  Google Scholar 

  91. Chung WY, Chang HS, Kim EK, Park CS. Ultrasonographic mass screening for thyroid carcinoma: a study in women scheduled to undergo a breast examination. Surg Today 2001; 31:763–767.

    Article  PubMed  CAS  Google Scholar 

  92. Koike E, Shiro N, Yamashita H, et al. Ultrasonographic characteristics of thyroid nodules: Prediction of malignancy. Arch Surg 2001; 136:334–337.

    Article  PubMed  CAS  Google Scholar 

  93. Papini E, Guglielmi R, Gianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002; 87:1941–1946.

    Article  PubMed  CAS  Google Scholar 

  94. Rago T, Vitti P, Chiovato L, et al. Role of conventional ultrasonography and color flow-Doppler sonography in predicting malignancy in ‘cold’ thyroid nodules. Eur J Endocrinol 1998; 138:41–46

    Article  PubMed  CAS  Google Scholar 

  95. Solbiati L, Charboneau JW, James EM, Hat ID. The thyroid gland. In Rumack CM, Wilson SR, Charboneau JW, editors. Diagnostic Ultrasound, 2nd ed. St Louis, MO: Mosby-Yearbook, 1998; 703–729.

    Google Scholar 

  96. Shapiro RS. Panoramic ultrasound of the thyroid. Thyroid 2003; 13:177–181.

    Article  PubMed  Google Scholar 

  97. Nam-Goong IS, Kim HY, Gong G, et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with patholological findings. Clin Endocrinol 2004; 60:21–28.

    Article  Google Scholar 

  98. Leenhardt L, Hejblum G, Franc B, et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 1999; 84:24–28.

    Article  PubMed  CAS  Google Scholar 

  99. Bellantone R, Lombardi CP, Raffaelli M, et al. Management of cystic or predominantly cystic thyroid nodules: The role of ultrasoundguided fine-needle aspiration biopsy. Thyroid 2004; 14:43–47.

    Article  PubMed  Google Scholar 

  100. Alexander EK, Heering JP, Benson CB, et al. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab 2002; 87:4924–4927.

    Article  PubMed  CAS  Google Scholar 

  101. Braga M, Cavalcanti TC, Collaco LM, Graf H. Efficacy of ultrasoundguided fine-needle aspiration biopsy in the diagnosis of complex thyroid nodules. J Clin Endocrinol Metab 2001; 86:4089–4091.

    Article  PubMed  CAS  Google Scholar 

  102. Dossing H, Bennedbaek FN, Karstrup S, Hegedus L. Benign solitary solid cold thyroid nodules: US-guided interstitial laser photocoagulation—initial experience. Radiology 2002; 225:53–57.

    Article  PubMed  Google Scholar 

  103. Pacini F. Role of percutaneous ethanol injection in management of nodular lesions of the thyroid gland. J Nucl Med 2003; 44:211–212.

    PubMed  Google Scholar 

  104. Fukunari N, Nagahama M, Sugino K, Mimura T, Ito K, Ito K. Clinical evaluation of color Doppler imaging for the differential diagnosis of thyroid follicular lesions. World J Surg 2004; 28:1261–1265.

    Article  PubMed  Google Scholar 

  105. Burguera B, Gharib H. Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 2000; 29:187–203.

    Article  PubMed  CAS  Google Scholar 

  106. Bailey Rh, Aron DC. The diagnostic dilemma of incidentalomas: Working through uncertainty. Endocrinol Metab Clin North Am 2000; 29:91–105.

    Article  PubMed  CAS  Google Scholar 

  107. Van den Bruel A, Maes A, De Potter T, et al. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab 2002; 87:1517–1520.

    Article  PubMed  Google Scholar 

  108. Cohen MS, Arslan N, Dehdashti F, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130:941–946.

    Article  PubMed  CAS  Google Scholar 

  109. Kang HW, Kim S-K, Kang H-S, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003; 88:4100–4104.

    Article  PubMed  CAS  Google Scholar 

  110. Kang HW, No JH, Chung JH, et al. Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas. Thyroid 2004; 14:29–33.

    Article  PubMed  Google Scholar 

  111. Silver RJ, Parangi S. Management of thyroid incidentalomas. Surg Clin North Am 2004; 84:907–919.

    Article  PubMed  Google Scholar 

  112. Raffel A, Cupisti K, Krausch M, et al. Incidentally found medullary thyroid cancer: treatment rationale for small tumors. World J Surg 2004; 28:397–401.

    Article  PubMed  Google Scholar 

  113. Quadbeck B, Pruellage J, Roggenbuck U, et al. Long-term follow-up of thyroid nodule growth. Exp Clin Endocrinol Diab 2002; 110:348–354.

    Article  CAS  Google Scholar 

  114. Alexander EK, Hurwitz S, Heering JP, et al. Natural history of benign solid and cystic thyroid nodules. Ann Intern Med 2003; 138:315–318.

    PubMed  Google Scholar 

  115. Zelmanovitz R, Genro S, Gross JL. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 1998; 83:3881–3885.

    Article  PubMed  CAS  Google Scholar 

  116. Gharib H, Mazzaferri EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998; 128:386–394.

    PubMed  CAS  Google Scholar 

  117. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a metaanalysis. J Clin Endocrinol Metab 2002; 87:4154–4159.

    Article  PubMed  CAS  Google Scholar 

  118. Ridgway EC. Medical treatment of benign thyroid nodules: Have we defined a benefit? Ann Intern Med 1998; 128:403–405.

    PubMed  CAS  Google Scholar 

  119. Hoermann R. Thyroid-hormone suppressive therapy in benign thyroid nodules—is it effective? Lancet 2002; 360:1899–1900.

    Article  PubMed  Google Scholar 

  120. Gharib H, James EM, Charboneau JW. Suppressive therapy with levothyroxine for solitary nodules. N Engl J Med 1987; 317:70–75.

    Article  PubMed  CAS  Google Scholar 

  121. Reverter JL, Lucas A, Salinas I, et al. Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol 1992; 36:25–28.

    CAS  Google Scholar 

  122. Papini E, Petrucci L, Guglielmi R, et al. Long term changes in nodular goiter: a 5 year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998; 83:780–783.

    Article  PubMed  CAS  Google Scholar 

  123. Cheung PSY, Lee JMH, Boey JH. Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg 1989; 13:818–822.

    Article  PubMed  CAS  Google Scholar 

  124. Celani MF, Mariani M, Mariani G. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid, or predominantly solid thyroid nodules. Acta Endocrinol 1990; 123:603–608.

    PubMed  CAS  Google Scholar 

  125. Papini E, Bacci V, Panunzi C, et al. A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol 1993; 38:507–513.

    CAS  Google Scholar 

  126. LaRosa GL, Lupo L, Giuffrida D, et al. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 1995; 122:1–8.

    CAS  Google Scholar 

  127. Lima N, Knobel M, Cavaliere H, et al. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 1997; 7:691–697.

    PubMed  CAS  Google Scholar 

  128. Wemeau JL, Caron P, Schvartz C, et al. Effects of TSH suppression with levothyroxine in reducing volume of solitary thyroid nodules and improving extranodular nonpalpable changes. J Clin Endocrinol Metab 2002; 87:4928–4934.

    Article  PubMed  CAS  Google Scholar 

  129. La Rosa GL, Ippolito AM, Lupo L, et al. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. J Clin Endocrinol Metab 1996; 81:4385–4387.

    Article  PubMed  Google Scholar 

  130. Stathatos N, Wartofsky L. Effects of thyroid hormone on bone. Clin Rev Bone Mineral Metab 2004; 2:135–150.

    Article  CAS  Google Scholar 

  131. Marcocci C, Golia F, Bruno-Bossio G, et al. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 1994; 78:818–823.

    Article  PubMed  CAS  Google Scholar 

  132. Koc M, Ersoz HO, Akpinar I, et al. Effect of low-and high-dose levothyroxine on thyroid nodule volume: a crossover placebocontrolled trial. Clin Endocrinol 2002; 57:621–628.

    Article  CAS  Google Scholar 

  133. Fogelfeld L, Wiviott MBT, Shore-Freedman E, et al. Recurrence of thyroid nodules after surgical removal in patients irradiated in childhood for benign conditions. N Engl J Med 1989; 320:835–840.

    Article  PubMed  CAS  Google Scholar 

  134. Hennessey JV, Evaul JE, Tseng YL, et al. L-thyroxine dosage: A re-evaluation of therapy with contemporary preparations. Ann Intern Med 1986; 105:11–16.

    PubMed  CAS  Google Scholar 

  135. Wartofsky L, Oertel Y. Fine needle aspiration biopsy of thyroid nodules. In Van Nostrand D, editor. Nuclear Medicine Atlas. Philadelphia: J. B. Lippincott, 1987; 193–200.

    Google Scholar 

  136. Hayashida N, Namba H, Kumagai A, et al. A rapid and simple detection method for the BRAFT1796A mutation in fine needle aspirated thyroid carcinoma cells. Thyroid 2004; 14:910–915.

    Article  PubMed  CAS  Google Scholar 

  137. Xing M, Tufano RP, Tufaro AP, et al. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab 2004; 89:2867–2872.

    Article  PubMed  CAS  Google Scholar 

  138. Mandel SJ. A 64 year old woman with a thyroid nodule. JAMA 2004; 292:2632–2642.

    Article  PubMed  CAS  Google Scholar 

  139. Alexander EK, Marqusee E, Orcutt J, et al. Thyroid nodule shape and prediction of malignancy. Thyroid 2004; 14:953–958.

    Article  PubMed  Google Scholar 

  140. Hamburger JI, Hamburger SW. Fine needle biopsy of thyroid nodules: avoiding the pitfalls. NY State J Med 1986; 86:241–249.

    CAS  Google Scholar 

  141. Rosen IB, Palmer JA, Bain J, et al. Efficacy of needle biopsy in postradiation thyroid disease. Surgery 1983; 94:1002–1007.

    PubMed  CAS  Google Scholar 

  142. Duek DS, Goldenberg D, Linn S, et al. The role of fine-needle aspiration and intaoperative frozen section in the surgical management of solitary thyroid nodules. Surg Today 2002; 32:857–861.

    Article  PubMed  Google Scholar 

  143. Lennquist S. The thyroid nodule: diagnosis and surgical treatment. Surg Clin North Am 1987; 67:213–232.

    PubMed  CAS  Google Scholar 

  144. Finley DJ, Zhu B, Barden CB, Fahey TJ III. Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann Surg 2004; 240:425–437.

    Article  PubMed  Google Scholar 

  145. Norton JA, Doppman JL, Jensen RT. Cancer of the endocrine system. In Devita VT Jr, Hellman L, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Philadelphia: J. B. Lippincott, 1989; 1269–1287.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Washington Hospital Center, Washington, DC

    Leonard Wartofsky MD, MACP (Chairman, Professor of Medicine)

  2. Anatomy, Physiology and Genetics, Uniformed Services University of Health Sciences, Bethesda, MD

    Leonard Wartofsky MD, MACP (Chairman, Professor of Medicine)

  3. Georgetown University School of Medicine, Washington, DC

    Leonard Wartofsky MD, MACP (Chairman, Professor of Medicine)

Authors
  1. Leonard Wartofsky MD, MACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Washington Hospital Center, Washington, DC

    Leonard Wartofsky MD, MPH, MACP  & Douglas Van Nostrand MD, FACP, FACNP  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Wartofsky, L. (2006). The Thyroid Nodule. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Humana Press. https://doi.org/10.1007/978-1-59259-995-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-995-0_17

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-462-3

  • Online ISBN: 978-1-59259-995-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation